SSRI during pregnancy and risk for fetal neurotoxicity: Be careful and look for treatment alternatives;SSRI under graviditet och risk för fetal neurotoxicitet: Följ försiktighetsprincipen och sök andra behandlingsalternativ

Lakartidningen

Volumn 102, Issue 3, 2005, Pages 113-115

  Högberg, Ulf ^a   Wang, Mingde ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

EXTRAPYRAMIDAL SYMPTOM; FETUS RISK; HUMAN; NERVE CONDUCTION; NEUROTOXICITY; PREGNANCY; PUERPERAL DEPRESSION; REVIEW; SEROTONINERGIC NERVE; SOMATOSENSORY CORTEX; TERATOGENICITY;

ANIMALS; BRAIN; DEPRESSION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; INFANT BEHAVIOR; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 13544253657     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Spigset O, Hägg S. Nya antidepressiva läkemedel under graviditet och amning. Läkemedelskoncentration bör följas och lägsta möjliga dos bör ges. Läkartidningen 2004;101(13):1176-81.
2. Nordeng H, Lindemann R, Perminov KV, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001;90(3):288-91.
3. Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003;142(4):402-8.
4. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159(11):1889-95.
5. Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M. Neonatal outcome following maternal antenatal depression and anxiety: a population-based study. Am J Epidemiol 2004;159(9):872-81.
6. Newport DJ, Stowe ZN. Clinical management of perinatal depression: focus on paroxetine. Psychopharmacol Bull 2003;37 Suppl 1:148-66.
7. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336(4):258-62.
8. Heikkinen T, Ekblad U, Palo P, Laine K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003;73(4):330-7.
9. Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;72(2):184-91.
10. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002;159(12):2055-61.
11. Vartazarmian R, Malik S, Baker GB, Boksa P. Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring. Psychopharmacology (Berl) 2004 Sep 10 [Epub ahead of print].
12. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004;306:879-81.
13. Oberlander TF, Eckstein Grunau R, Fitzgerald C, Ellwood AL, Misri S, Rurak D, et al. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res 2002;51(4):443-53.
14. Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 2001;65(1):21-37.
15. Bourgeois JP. Synaptogenesis in the neocortex of the newborn: the ultimate frontier for individuation? In: Lagercrantz H, Hansson, M, Evrard P, Rodeck C, editors. The newborn brain - Neuroscience and clinical applications. Cambridge: Cambridge University Press; 2002. p. 91-113.
16. Sundstrom I, Backstrom T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 1998;23(1):73-88.
17. Rubertsson C, Waldenström U, Wickberg B. Depressive mood in early pregnancy: prevalence and women at risk in a national Swedish sample. J Reprod Infant Psychology 2003;21:113-23.
18. Andersson L, Sundstrom-Poromaa I, Bixo M, Wulff M, Bondestam K, Strom M. Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol 2003;189(1):148-54.
19. Campagne DM. The obstetrician and depression during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004;116(2):125-30.
20. Hoffbrand S, Howard L, Crawley H. Antidepressant treatment for post-natal depression. Nurs Times 2001;97(45):35.